BioCentury
ARTICLE | Clinical News

Apatorsen: Phase II data

September 28, 2015 7:00 AM UTC

The double-blind, U.S. Phase II Rainier trial in about 130 treatment-naive patients with metastatic pancreatic cancer showed that IV apatorsen plus Abraxane nab-paclitaxel and gemcitabine missed the ...